Skip to main content
Intuitive SurgicalEarnings

Intuitive Surgical Stock Drops After da Vinci Recall Concerns Raise Investor Worries

What happened

Intuitive Surgical reported adjusted quarterly earnings of $2.80 per share, which was ahead of analyst estimates.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Table of Contents Intuitive Surgical stock drops on news of a fresh FDA recall of parts used in the company's da Vinci robotic surgery system, with investors reacting negatively. The leader in robotic surgery still reports strong financials, but the new recall notices and a conservative growth strategy have investors re-assessing the company's near-term prospects. The U.S. FDA has announced further Class II recall notifications for certain da Vinci system components, including the da Vinci SP Instrument Arm Drape and other components used in robotic-assisted surgical systems. The recalls concern particular parts that could impact system operation in certain circumstances, the agency said. Intuitive Surgical has notified consumers of corrective procedures and the communications are not a full recall of the affected systems. Recalls are not uncommon in the medical device sector, but the action taken on the company's flagship robotic surgery platform will be eagerly watched by investors. The platform generates recurrent revenue from procedures, instruments and service contracts. Intuitive Surgical still has good operating performance despite market reaction. The company just reported quarterly revenue of $2.89 billion, up about 19% year-over-year, while adjusted earnings came in at $2.80 per share, ahead of analyst estimates. The number of procedures continued to climb, driven...

Keep reading with a free account

The rest of this article, and every signal for Intuitive Surgical, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Earnings

What this signalsEarnings results often set the next budget cycle.

The full record

From the Signal API record

Numbers

Amount (USD)
$2

Extraction

Confidence
90%
Detected
Jul 17, 2026
signal_type
news
signal_subtype
has_earnings

Use this data

Get every earnings signal for Intuitive Surgical and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Intuitive Surgical this week?”

  2. Send it to your own tools

    The Signal API returns earnings signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/608cb2df-8ee0-fc12-56c6-265261b5576f returns this record as JSON. POST /v1/companies/enrich returns every signal for intuitive.com.

{
  "signal_id": "608cb2df-8ee0-fc12-56c6-265261b5576f",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-07-17T12:04:14+00:00",
  "company": {
    "name": "Intuitive Surgical",
    "domain": "intuitive.com"
  },
  "data": {
    "url": "https://chshyd.in/finance/intuitive-surgical-stock-drops/",
    "title": "Intuitive Surgical Stock Drops After da Vinci Recall Concerns Raise Investor Worries - chshyd.in",
    "excerpt": "Table of Contents Intuitive Surgical stock drops on news of a fresh FDA recall of parts used in the company’s da Vinci robotic surgery system, with investors reacting negatively. The leader in robotic surgery still reports strong financials, but the new recall notices and a conservative growth strategy have investors re-assessing the company’s near-term prospects. The U.S. FDA has announced further Class II recall notifications for certain da Vinci system components, including the da Vinci SP Instrument Arm Drape and other components used in robotic-assisted surgical systems. The recalls concern particular parts that could impact system operation in certain circumstances, the agency said. Intuitive Surgical has notified consumers of corrective procedures and the communications are not a full recall of the affected systems. Recalls are not uncommon in the medical device sector, but the action taken on the company’s flagship robotic surgery platform will be eagerly watched by investors. The platform generates recurrent revenue from procedures, instruments and service contracts. Intuitive Surgical still has good operating performance despite market reaction. The company just reported quarterly revenue of $2.89 billion, up about 19% year-over-year, while adjusted earnings came in at $2.80 per share, ahead of analyst estimates. The number of procedures continued to climb, driven by...",
    "summary": "Intuitive Surgical reported adjusted quarterly earnings of $2.80 per share, which was ahead of analyst estimates.",
    "planning": false,
    "image_url": "https://chshyd.in/wp-content/uploads/2026/07/Intuitive-Surgical-Stock-Drops.jpg",
    "confidence": 0.9,
    "published_at": "2026-07-17T12:04:14Z",
    "article_sentence": "The company just reported quarterly revenue of $2.89 billion, up about 19% year-over-year, while adjusted earnings came in at $2.80 per share, ahead of analyst estimates.",
    "amount_normalized": 2
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.